Helen Burstin, MD, MPH, FACP, chief scientific officer of The National Quality Forum, said that quality measurement is at the core of transitioning to value-based payment, and that the initiative can’t truly move forward without putting the work in to identify and define what that value is.
Helen Burstin, MD, MPH, FACP, chief scientific officer of The National Quality Forum, said that quality measurement is at the core of transitioning to value-based payment, and that the initiative can’t truly move forward without putting the work in to identify and define what that value is.
Transcript (slightly modified)
What is the National Quality Forum’s involvement in the Core Quality Measures Collaborative?
NQF’s been engaged in the CMS AHIP measures collaborative from the very beginning, actually, and have played several important roles. I think one of which is to be a technical advisor as the different work groups are focused on a particular content area. We could bring forward all the endorsed measures in that space. We could point to particular measures that maybe they wouldn’t have thought of otherwise but we’ve really been engaged as part of those efforts.
And then lastly, we’ve also been engaged in ensuring that the collaborative had a broader set of stakeholders at the table as it moved beyond the initial plan, the physician groups and now to a broader set of stakeholders.
What is the role of quality measurement in the move toward value-based care?
It is clear that measurement is core towards making that transition to value-based payment. We can’t move forward with doing work based on really identifiying the value, which is combination of cost and outcomes in particular, unless you’ve got those outcomes ready to go. So we really see measurement as being core to that shift to value-based purchasing.
And in fact, if we perform well in outcomes, our hope would be, we would ultimately reduce costs and really get a better value. That being said, there are a fair number of measurement gaps. Gaps in terms of the outcomes where they are, so one of our visions is to try to be out there, finding out where the best possible measures are, harvesting for those, bringing them forward and trying to get them used as part of these national efforts.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More